Isotretinoin treatment of acne in a patient with Apert syndrome.

Apert syndrome is an autosomal dominant disease caused by mutations in fibroblast growth factor receptor (FGFR-2) and characterized by premature fusion of the cranial sutures and early epiphyseal closure. The development of widespread, severe, pustular acne around puberty is a characteristic feature in these patients. The FGFR-2 mutation of Apert syndrome has been described in localized nevoid acne lesions, which have been attributed to somatic mosaicism. Isotretinoin has been reported to be useful in controlling this acne. We report the successful treatment of acne with isotretinoin in a teenager with Apert syndrome and review the pathophysiology of acne in this syndrome.
AuthorsMontserrat Gilaberte, Lluis Puig, Agustín Alomar
JournalPediatric dermatology (Pediatr Dermatol) 2003 Sep-Oct Vol. 20 Issue 5 Pg. 443-6 ISSN: 0736-8046 [Print] United States
PMID14521567 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Isotretinoin
  • Acne Vulgaris (drug therapy, physiopathology)
  • Acrocephalosyndactylia (complications)
  • Adolescent
  • Humans
  • Isotretinoin (therapeutic use)
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: